Bionik Laboratories BNKL · USD

Market value

$1,248

Last close × shares

Volume

578

Shares, 30 Oct 2026

Its shares trade under the ticker BNKL. It has been listed since 12 June 2012. In the fiscal year to 31 March 2023, it reported revenue of $1.8m and a net loss of $4.9m. At that date it held total assets of $3.4m and shareholders' equity of −$1.6m.

Bionik Laboratories Corp. engages in the provision of rehabilitation and mobility solutions to individuals with neurological disorders. The company is headquartered in Watertown, Massachusetts. The company went IPO on 2012-06-12. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and deliver recovery for patients with neurological or mobility impairments. The company has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients, including three products on the market and three products in varying stages of development. Its InMotion ARM, and InMotion ARM/HAND products are robotic therapies for the upper limbs. In addition to these fully developed, clinical rehabilitation solutions, it is also developing InMotion Home, which is an upper extremity product that allows the patient to extend their therapy for as long as needed while rehabilitating at home. Its other products are InMotion Robots and InMotion CONNECT.

Figures and description from our data supplier, not checked against the company's own report.

More about Bionik Laboratories →

• Bionik Laboratories Announces Agreement with The Transitional Learning Center for InMotion Arm Robotic Systems 22 Jun 2018

Leaves out fees, taxes and financing.

Chart

TradingView

Close and company data

Our data supplier

News

Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.